349 related articles for article (PubMed ID: 35360111)
21. Potential role of gut microbiota and tissue barriers in Parkinson's disease and amyotrophic lateral sclerosis.
Fang X
Int J Neurosci; 2016 Sep; 126(9):771-6. PubMed ID: 26381230
[TBL] [Abstract][Full Text] [Related]
22. Changes in the concentrations of trimethylamine N-oxide (TMAO) and its precursors in patients with amyotrophic lateral sclerosis.
Chen L; Chen Y; Zhao M; Zheng L; Fan D
Sci Rep; 2020 Sep; 10(1):15198. PubMed ID: 32938991
[TBL] [Abstract][Full Text] [Related]
23. Amyotrophic lateral sclerosis and intestinal microbiota-toward establishing cause and effect.
Gotkine M; Kviatcovsky D; Elinav E
Gut Microbes; 2020 Nov; 11(6):1833-1841. PubMed ID: 32501768
[TBL] [Abstract][Full Text] [Related]
24. Why do motor neurons degenerate? Actualization in the pathogenesis of amyotrophic lateral sclerosis.
Riancho J; Gonzalo I; Ruiz-Soto M; Berciano J
Neurologia (Engl Ed); 2019; 34(1):27-37. PubMed ID: 26853842
[TBL] [Abstract][Full Text] [Related]
25. Interplay among gut microbiota, intestinal mucosal barrier and enteric neuro-immune system: a common path to neurodegenerative diseases?
Pellegrini C; Antonioli L; Colucci R; Blandizzi C; Fornai M
Acta Neuropathol; 2018 Sep; 136(3):345-361. PubMed ID: 29797112
[TBL] [Abstract][Full Text] [Related]
26. A prospective longitudinal study on the microbiota composition in amyotrophic lateral sclerosis.
Di Gioia D; Bozzi Cionci N; Baffoni L; Amoruso A; Pane M; Mogna L; Gaggìa F; Lucenti MA; Bersano E; Cantello R; De Marchi F; Mazzini L
BMC Med; 2020 Jun; 18(1):153. PubMed ID: 32546239
[TBL] [Abstract][Full Text] [Related]
27. Pathogenic or protective? Neuropeptide Y in amyotrophic lateral sclerosis.
Clark CM; Clark RM; Hoyle JA; Dickson TC
J Neurochem; 2021 Feb; 156(3):273-289. PubMed ID: 32654149
[TBL] [Abstract][Full Text] [Related]
28. The Microbiome as a Modifier of Neurodegenerative Disease Risk.
Fang P; Kazmi SA; Jameson KG; Hsiao EY
Cell Host Microbe; 2020 Aug; 28(2):201-222. PubMed ID: 32791113
[TBL] [Abstract][Full Text] [Related]
29. Healthy Gut, Healthy Brain: The Gut Microbiome in Neurodegenerative Disorders.
Chandra S; Alam MT; Dey J; Sasidharan BCP; Ray U; Srivastava AK; Gandhi S; Tripathi PP
Curr Top Med Chem; 2020; 20(13):1142-1153. PubMed ID: 32282304
[TBL] [Abstract][Full Text] [Related]
30. Gut inflammation and dysbiosis in human motor neuron disease.
Rowin J; Xia Y; Jung B; Sun J
Physiol Rep; 2017 Sep; 5(18):. PubMed ID: 28947596
[TBL] [Abstract][Full Text] [Related]
31. The Serotonergic System and Amyotrophic Lateral Sclerosis: A Review of Current Evidence.
Yang L; Cheng Y; Zhu Y; Cui L; Li X
Cell Mol Neurobiol; 2023 Aug; 43(6):2387-2414. PubMed ID: 36729314
[TBL] [Abstract][Full Text] [Related]
32. The human gut microbiota in people with amyotrophic lateral sclerosis.
Nicholson K; Bjornevik K; Abu-Ali G; Chan J; Cortese M; Dedi B; Jeon M; Xavier R; Huttenhower C; Ascherio A; Berry JD
Amyotroph Lateral Scler Frontotemporal Degener; 2021 May; 22(3-4):186-194. PubMed ID: 33135936
[TBL] [Abstract][Full Text] [Related]
33. The Current Potential Pathogenesis of Amyotrophic Lateral Sclerosis.
Jiang S; Xu R
Mol Neurobiol; 2024 Jun; ():. PubMed ID: 38829511
[TBL] [Abstract][Full Text] [Related]
34. Therapeutics for neurodegenerative diseases by targeting the gut microbiome: from bench to bedside.
Ma YY; Li X; Yu JT; Wang YJ
Transl Neurodegener; 2024 Feb; 13(1):12. PubMed ID: 38414054
[TBL] [Abstract][Full Text] [Related]
35. Sensory nerve disturbance in amyotrophic lateral sclerosis.
Tao QQ; Wei Q; Wu ZY
Life Sci; 2018 Jun; 203():242-245. PubMed ID: 29709651
[TBL] [Abstract][Full Text] [Related]
36. Reduction of ephrin-A5 aggravates disease progression in amyotrophic lateral sclerosis.
Rué L; Oeckl P; Timmers M; Lenaerts A; van der Vos J; Smolders S; Poppe L; de Boer A; Van Den Bosch L; Van Damme P; Weishaupt JH; Ludolph AC; Otto M; Robberecht W; Lemmens R
Acta Neuropathol Commun; 2019 Jul; 7(1):114. PubMed ID: 31300041
[TBL] [Abstract][Full Text] [Related]
37. Neuron-specific antioxidant OXR1 extends survival of a mouse model of amyotrophic lateral sclerosis.
Liu KX; Edwards B; Lee S; Finelli MJ; Davies B; Davies KE; Oliver PL
Brain; 2015 May; 138(Pt 5):1167-81. PubMed ID: 25753484
[TBL] [Abstract][Full Text] [Related]
38. Microglial TREM2 in amyotrophic lateral sclerosis.
Xie M; Zhao S; Bosco DB; Nguyen A; Wu LJ
Dev Neurobiol; 2022 Jan; 82(1):125-137. PubMed ID: 34874625
[TBL] [Abstract][Full Text] [Related]
39. Neutral Lipid Cacostasis Contributes to Disease Pathogenesis in Amyotrophic Lateral Sclerosis.
Dodge JC; Jensen EH; Yu J; Sardi SP; Bialas AR; Taksir TV; Bangari DS; Shihabuddin LS
J Neurosci; 2020 Nov; 40(47):9137-9147. PubMed ID: 33051352
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
